Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now later-stage tilt small index

Uterine Bleeding: later-stage trial registry

2 of 2 indexed Uterine Bleeding trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 2 currently recruiting · #7,188 of 28,707 conditions by registered trial count

Uterine Bleeding: 2 US clinical trials tracked, 2 recruiting.

Uterine Bleeding is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Baylor College of Medicine, running 1 of these trials.

Enrollment posture brief

Registry condition uterine-bleeding

OPEN 2 | RECR 100% | LATE 1 | EARLY 0 | RANK #7188 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Uterine Bleeding (this)100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Uterine Bleeding

Uterine Bleeding lists 2 open slots (100% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Uterine Bleeding on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Uterine Bleeding is recruiting above its size-band peers.

    2 of 2 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 31

Phase Distribution

PhaseTrial count
Phase 3 1

Named interventions

Most-linked intervention names on Uterine Bleeding records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Ferrous Sulfate 65 mg elemental iron (325 mg tablets) Drug
1 trials
Ferric Derisomaltose 1000 Mg in 10 mL INTRAVENOUS SOLUTION [Monoferric] Drug
1 trials
Video on uterine fibroids Behavioral
1 trials

US sites by state

Facility locations filed on Uterine Bleeding trials. A trial with sites in several states counts in each.

Texas 1 trials
Pennsylvania 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Uterine Bleeding page

2 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Uterine Bleeding condition card totals 2 registered trials; most-linked intervention Ferrous Sulfate 65 mg elemental iron (325 mg tablets); top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.